SC10: CAR T Cell Therapy from A-Z
Monday, August 31
ABOUT THIS COURSE:
This course will provide an overview of the history of the CAR T cell platform including early successes and failures. It will review learnings from the non-clinical and clinical evaluation of CAR T cells in hematologic malignancies and solid tumors. It will discuss challenges encountered with the current CAR T cell formats and approaches to address these challenges followed by discussion of the next generation CAR T cells including technical improvements and therapeutic opportunities.
TOPICS TO BE COVERED INCLUDE:
- History of the CAR T cell platform including early successes and failures
- Learnings from the clinical evaluation of CAR T cells in hematological malignancies
- Learnings from the clinical evaluation of CAR T cells in solid tumors
- Challenges with the current CAR T cell formats and approaches to address these challenges
- The next generation of CAR T cells: Technical advances, limitations and opportunities
INSTRUCTOR BIOGRAPHY:
Tara Arvedson, PhD, Director, Oncology Research, Amgen
Tara Arvedson, Executive Director in Oncology Research at Amgen, has led multiple T cell therapeutic programs and is currently responsible for a large portfolio of T cell therapeutic assets and platform strategy. She received her Ph.D. at Caltech and was later a Damon Runyon Cancer Research Fellow at UC San Diego.